Changing the Lives of Patients with

Myotubular and Centronuclear Myopathies (CNM)

Patients & Families

Patients are at the core of what we do. We are grateful for the collaboration and education that has come from the CNM community globally, from patients and families, to advocacy leaders and healthcare providers. We are particularly aware of the contributions of those who have participated in all studies, including our own. Your contributions are crucial to Dynacure’s success in finding safe and effective treatments for CNM and HSP. We want to thank you.

Meet Lynn
Meet Sebastian
Meet Declan
Meet Ashley
Meet Evan
Meet Prince
Meet Morice
Meet Zak
Meet Wiktor

Our Commitment to Patients

Learn More
“Patients are at the core of what we do. We are committed to delivering therapeutic solutions to patients living with progressive diseases like CNM and HSP,”
- Chris Freitag (M.D.), Chief Medical Officer

For questions or to request
to stay in touch with us
please reach out to:
patients@dynacure.com

“Patients are at the core of what we do. We are committed to delivering therapeutic solutions to patients living with progressive diseases like CNM and HSP”
- Chris Freitag (M.D.), Chief Medical Officer

Join the Dynacure Family

Get updates from Dynacure for patients and families.

Thank you for registering to stay in touch with us.
There was an error trying to send your message. Please try again later.

Our current clinical trials

If you believe you or a loved one might be a good candidate for our trials, we encourage you to visit clinicaltrials.gov or speak to your physician.

Our Clinical Trial FAQ

Unite-CNM clinical trial FAQ documents in following languages

Letter From our CEO

Download